[HTML][HTML] MYCN impact on high-risk neuroblastoma: from diagnosis and prognosis to targeted treatment

D Bartolucci, L Montemurro, S Raieli, S Lampis… - Cancers, 2022 - mdpi.com
Simple Summary Neuroblastoma is one of the most diffuse and the deadliest cancer in
children. While many advances have been made in the last few decades to improve patients' …

Diagnostic and therapeutic approaches for glioblastoma and neuroblastoma cancers using chlorotoxin nanoparticles

T Boltman, M Meyer, O Ekpo - Cancers, 2023 - mdpi.com
Simple Summary Glioblastoma multiforme (GB) and neuroblastomas (NBs) are nervous
system cancers that are difficult to diagnosis and treat. Chlorotoxin (CTX), is a peptide …

Single-cell transcriptomics and epigenomics unravel the role of monocytes in neuroblastoma bone marrow metastasis

IS Fetahu, W Esser-Skala, R Dnyansagar… - Nature …, 2023 - nature.com
Metastasis is the major cause of cancer-related deaths. Neuroblastoma (NB), a childhood
tumor has been molecularly defined at the primary cancer site, however, the bone marrow …

The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma

M Pan, WC Wright, RH Chapple, A Zubair… - Nature …, 2021 - nature.com
Survival in high-risk pediatric neuroblastoma has remained around 50% for the last 20
years, with immunotherapies and targeted therapies having had minimal impact. Here, we …

[HTML][HTML] Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory

X Yuan, JA Seneviratne, S Du, Y Xu, Y Chen, Q **… - Cell Reports, 2022 - cell.com
Peripheral neuroblastic tumors (PNTs) represent a spectrum of neural-crest-derived tumors,
including neuroblastoma, ganglioneuroblastoma, and ganglioneuroma. Malignant cells in …

The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma

AS Pathania, H Chava, NK Chaturvedi, S Chava… - Cell Death & …, 2024 - nature.com
Neuroblastoma (NB) is a highly aggressive pediatric cancer that originates from immature
nerve cells, presenting significant treatment challenges due to therapy resistance. Despite …

Schwann cell plasticity regulates neuroblastic tumor cell differentiation via epidermal growth factor-like protein 8

T Weiss, S Taschner-Mandl, L Janker, A Bileck… - Nature …, 2021 - nature.com
Abstract Adult Schwann cells (SCs) possess an inherent plastic potential. This plasticity
allows SCs to acquire repair-specific functions essential for peripheral nerve regeneration …

MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment

L Garcia-Gerique, M García, A Garrido-Garcia… - BMC cancer, 2022 - Springer
Background The bone marrow (BM) is the most common site of dissemination in patients
with aggressive, metastatic neuroblastoma (NB). However, the molecular mechanisms …

[HTML][HTML] Landscape of bone marrow metastasis in human neuroblastoma unraveled by transcriptomics and deep multiplex imaging

D Lazic, F Kromp, F Rifatbegovic, P Repiscak, M Kirr… - Cancers, 2021 - mdpi.com
Simple Summary Bone marrow metastasis frequently occurs in patients with solid cancers
and most often leads to poor outcome. Yet, the composition of bone marrow metastases …

A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations

IM Saldana-Guerrero, LF Montano-Gutierrez… - Nature …, 2024 - nature.com
Early childhood tumours arise from transformed embryonic cells, which often carry large
copy number alterations (CNA). However, it remains unclear how CNAs contribute to …